Literature DB >> 628191

Effect of prolonged low-dose infusions of ile5-angiotensin ii on blood pressure, aldosterone and electrolyte excretion in sodium replete man.

W Oelkers, M Schöneshöfer, G Schultze, B Bauer.   

Abstract

Two healthy young males on a constant normal sodium diet (135 mM/day) were infused for 132 h with 3 ng/kg/min of angiotensin II. Plasma angiotensin II levels were therby raised to the range of moderate sodium depletion. Plasma aldosterone and the urinary excretion rate of aldosterone-18-glucuronide were markedly increased during the whole infusion period and returned to control levels after the infusion was stopped. A slight tendency of aldosterone secretion to decrease towards the end of infusion was probably due to sodium retention (appr. 200 mM and 350 mM respectively) and to a fall in plasma potassium by approximately 0.5 mM/1. Plasma aldosterone during infusion, maintained circadian variations similar to those of cortisol. Plasma cortisol patterns were unaffected by angiotensin II. Blood pressure increased gradually during angiotensin II infusion, reflecting changes in sodium balance. The results, differing from those of studies in dog and sheep, support the assumption that angiotensin II is an important regulator of aldosterone secretion in man rather than a merely permissive factor.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 628191     DOI: 10.1007/bf01476741

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  14 in total

1.  Role of angiotensin II and potassium in the long-term regulation of aldosterone secretion in intact conscious dogs.

Authors:  R E McCaa; C S McCaa; A C Guyton
Journal:  Circ Res       Date:  1975-06       Impact factor: 17.367

2.  EFFECTS OF PROLONGED INFUSION OF ANGIOTENSIN II IN NORMAL DOGS.

Authors:  J URQUHART; J O DAVIS; J T HIGGINS
Journal:  Am J Physiol       Date:  1963-12

3.  PROLONGED INFUSIONS OF ANGIOTENSIN II AND NOREPINEPHRINE AND BLOOD PRESSURE, ELECTROLYTE BALANCE, AND ALDOSTERONE AND CORTISOL SECRETION IN NORMAL MAN AND IN CIRRHOSIS WITH ASCITES.

Authors:  R P AMES; A J BORKOWSKI; A M SICINSKI; J H LARAGH
Journal:  J Clin Invest       Date:  1965-07       Impact factor: 14.808

4.  Effect of prolonged low-dose angiotensin II infusion on the sensitivity of adrenal cortex in man.

Authors:  W Oelkers; M Schöneshöfer; G Schultze; J J Brown; R Fraser; J J Morton; A F Lever; J I Robertson
Journal:  Circ Res       Date:  1975-06       Impact factor: 17.367

Review 5.  The adrenal cortex and essential hypertension.

Authors:  J Genest; W Nowaczynski; O Kuchel; R Boucher; J M Rojo-Ortega; G Constantopoulos; D Ganten; F Messerli
Journal:  Recent Prog Horm Res       Date:  1976

6.  Effects of progesterone and four synthetic progestagens on sodium balance and the renin-aldosterone system in man.

Authors:  W Oelkers; M Schöneshöfer; A Blümel
Journal:  J Clin Endocrinol Metab       Date:  1974-11       Impact factor: 5.958

7.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

8.  Isolation and amino acid composition of human angiotensin I.

Authors:  K Arakawa; M Nakatani; A Minohara; M Nakamura
Journal:  Biochem J       Date:  1967-09       Impact factor: 3.857

9.  Radioimmunoassay of free aldosterone and of its 18-oxo-glucuronide in human urine.

Authors:  P Vecsei; B Penke; A Joumaah
Journal:  Experientia       Date:  1972-05-15

10.  Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man.

Authors:  N K Hollenberg; W R Chenitz; D F Adams; G H Williams
Journal:  J Clin Invest       Date:  1974-07       Impact factor: 14.808

View more
  1 in total

1.  Validation of an integrative mathematical model of dehydration and rehydration in virtual humans.

Authors:  W Andrew Pruett; John S Clemmer; Robert L Hester
Journal:  Physiol Rep       Date:  2016-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.